Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Myeloid Leukemia
Clinical trial NCT04923919 · UNKNOWN
Trial details
- NCT number
- NCT04923919
- Sponsor
- 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-14
- Primary completion
- 2024-12-05
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.